TOKYO -- Japan materials group Toray Industries will apply this year for fast-track government approval to sell a cancer screening test that requires only one drop of blood.
The method can screen for multiple types of cancer at once and has a precision rate of more than 95%, according to Toray, holding to the potential to contribute to early detection of hard-to-diagnose forms of the disease, such as pancreatic cancer.
